Business · 10/11/1998Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for Neuro Cybernetic Prosthesis System
Summary
The US Food and Drug Administration (FDA) has officially approved the regulatory review period for the Neuro Cybernetic Prosthesis (NCP) System, a medical device, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →